Why Vildagliptina/Metformina Sandoz is in shortage
supply-chain disruption — e.g. “Existe/n otro/s medicamento/s con los mismos principios activos y para la misma vía de administración.” (Spain)
Recent shortage history
Spain: resolved 14 Oct 2026 (began 27 Aug 2026)
Spain: resolved 26 Aug 2026 (began 9 Jul 2026)
Spain: resolved 26 Aug 2026 (began 1 Jul 2026)
Spain: resolved 29 Apr 2026 (began 4 Feb 2026)
Spain: resolved 21 Jan 2026 (began 2 Nov 2025)
Spain: resolved 17 Sept 2025 (began 24 Aug 2025)
Spain: resolved 28 Aug 2025 (began 6 May 2025)
Frequently asked questions
Is Vildagliptina/Metformina Sandoz currently in shortage?
Yes. As of the latest regulator updates, Vildagliptina/Metformina Sandoz has 2 active shortage notices across 1 country (Spain). Status is refreshed daily from official regulatory sources.
Why is Vildagliptina/Metformina Sandoz in shortage?
Regulators attribute the current Vildagliptina/Metformina Sandoz shortages to supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Vildagliptina/Metformina Sandoz shortage be resolved?
Regulator-estimated resolution dates currently range from 3 Dec 2026 to 10 Dec 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Vildagliptina/Metformina Sandoz shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Get alerted when Vildagliptina/Metformina Sandoz status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.